Partner With Us NRI

Company details

6M Return -29.83%
1Y Return -56.04%
Mkt Cap.(Cr) 4,023.60
Volume 67,264
Div Yield 0.00%
OI Chg %
Volume 67,264

Open Free Demat Account Online with ICICIDIRECT


  • swot

  • technicals

  • deals

  • shareholding


Delivery and volume


  • Profit and loss statement

  • Balance sheet

  • Quarterly Result

  • Ratio


Operating Profit(Cr.)

Profit after Tax(Cr.)


Reserves and Surplus



Operating Profit

Profit after tax





Equity Capital: 3,376.76 Cr FV: 5.00
Period MF Net Purchase / (sold) FII Net
LAST 1M 22,733.13 -37,122.02
LAST 3M 74,205.53 -50,398.80
LAST 6M 139,333.16 -187,387.57
LAST 12M 206,053.08 -175,138.09
  • Announcement
  • Corporate action
  • No Data Found

Date Action Type Ratio
No data found


  • About Company
  • Company Info
  • Listing Info
  • Wockhardt Ltd is in the Pharmaceuticals sector with the Market Capitalization of worth Rs. 5,314.72 crores, it is incorporated in the 1960s. It has reported consolidated sales of Rs. 764.02 crores in December’2020. The company is also listed in the Bombay Stock Exchange (BSE) with the code 532300 and listed in the National Stock Exchange (NSE) with the code WOCKPHARMA.

    Wockhardt is a global biotechnology and pharmaceuticals company with its headquarters based in Mumbai. Wockhardt is engaged in producing biopharmaceuticals, nutrition products, vaccines, formulations, and active pharmaceuticals ingredients (APIs). The company has various manufacturing plants in India and the USA. Notably, more than half of its revenue is generated in Europe. It has a market presence in many countries around the globe, such as India, the USA, UK, Brazil, Russia, Mexico, Kenya, Ghana, etc. Wockhardt Hospitals, a subsidiary of Wockhardt ltd is a healthcare network of tertiary care and super specialty healthcare services in India. These hospitals offer services in the fields of Cardiology, Orthopedics, Neurology, Gastroenterology, Urology, etc. The promoters of the company own 69.68% of the stake in the company, Foreign Institutional Investors (FII) own 2.73%, Domestic Institutional Investors (DII) own 0.09% of the stake, and others (such as public & retail investors) hold the balance of 27.50%.

    In June 2021, quarterly net revenue was Rs. 278.95 crores, which has increased by approximately 57.08 % from Rs. 177.58 crores for the April-June 2020 quarter. The quarterly net loss in June 2021 was Rs. 48.69 crores, which has seen a sharp decline by nearly 106.35% from a net profit of Rs. 766.39 crores in June 2020. In June 2021, the reported operating profit was at Rs. 199.96 crores, which is also reduced by 78.15% as compared to an operating profit of Rs. 915.08 crores for the quarter ending in June 2020. From Rs. 69.21 in June 2020, the EPS of Wockhardt Ltd has decreased to (Rs. 4.40) per share in June 2021. WOCKPHARMA’s stock closed at Rs. 488.50 on 17th August’2021 (NSE) and has returned -2.36% in the last six months and 49.78% in the previous year.

Read More

No Data Found

AGM Date (Month) : Aug
Face Value Equity Shares : 5
Market Lot Equity Shares : 1
BSE Code : 532300
Book Closure Date (Month) : Jul/Aug
BSE Group : A
ISIN : INE049B01025

ICICIdirect Wockhardt Ltd FAQ

You can buy Wockhardt Ltd shares through a brokerage firm. ICICIdirect is a registered broker through which you can place orders to buy Wockhardt Ltd Share.
Company share prices and volatile and keep changing according to the market conditions. As of May 24, 2022 04:01 PM the closing price of Wockhardt Ltd was ₹ 279.30.
Market capitalization or market cap is determined by multiplying the current market price of a company’s shares with the total number of shares outstanding. As of May 24, 2022 04:01 PM, the market cap of Wockhardt Ltd stood at ₹ 4,023.60.
The latest PE ratio of Wockhardt Ltd as of May 24, 2022 04:01 PM is 0
The latest PB ratio of Wockhardt Ltd as of May 24, 2022 04:01 PM is 1.02
The 52-week high of Wockhardt Ltd is ₹ 741.36 while the 52-week low is ₹ 228.80 .

Thank you for subscribing to Equity/ Equity Research/MF/FnO Newsletter. You will hear from us shortly.

for your vote